Loading ...
Sorry, an error occurred while loading the content.
 

The Nocebo Effect: Placebo's Evil Twin

Expand Messages
  • NHNE
    NHNE News List Current Members: 734 Subscribe/unsubscribe/archive info at the bottom of this message. ... THE NOCEBO EFFECT: PLACEBO S EVIL TWIN By Brian Reid
    Message 1 of 1 , May 2, 2002
      NHNE News List
      Current Members: 734
      Subscribe/unsubscribe/archive info at the bottom of this message.

      ------------

      THE NOCEBO EFFECT: PLACEBO'S EVIL TWIN
      By Brian Reid
      Special to The Washington Post
      Tuesday, April 30, 2002

      http://www.washingtonpost.com/wp-dyn/articles/A2709-2002Apr29.html

      Ten years ago, researchers stumbled onto a striking finding: Women who
      believed that they were prone to heart disease were nearly four times as
      likely to die as women with similar risk factors who didn't hold such
      fatalistic views.

      The higher risk of death, in other words, had nothing to with the usual
      heart disease culprits -- age, blood pressure, cholesterol, weight. Instead,
      it tracked closely with belief. Think sick, be sick.

      That study is a classic in the annals of research on the "nocebo"
      phenomenon, the evil twin of the placebo effect. While the placebo effect
      refers to health benefits produced by a treatment that should have no
      effect, patients experiencing the nocebo effect experience the opposite.
      They presume the worst, health-wise, and that's just what they get.

      "They're convinced that something is going to go wrong, and it's a
      self-fulfilling prophecy," said Arthur Barsky, a psychiatrist at Boston's
      Brigham and Women's Hospital who published an article earlier this year in
      the Journal of the American Medical Association beseeching his peers to pay
      closer attention to the nocebo effect. "From a clinical point of view, this
      is by no means peripheral or irrelevant."

      Barsky's target is drug side effects, which cost the U.S. health system more
      than $76 billion a year, according to a 1995 University of Arizona study. If
      even a small percentage of those costs are caused by patient expectations of
      harm, addressing the nocebo effect could save a nifty sum.

      But convincing doctors that their patients' problems may be more than
      biochemical is no simple trick. The nocebo effect is difficult to study, and
      medical training leads doctors to seek a bodily cause for physical ills.

      "Nocebos often cause a physical effect, but it's not a physically produced
      effect," said Irving Kirsch, a psychologist at the University of Connecticut
      in Storrs who studies the ways that expectations influence what people
      experience. "What's the cause? In many cases it's an unanswered question."

      Looking for Trouble

      The word nocebo, Latin for "I will harm," doesn't represent a new idea --
      just one that hasn't caught on widely among clinicians and scientists. More
      than four decades after researchers coined the term, only a few medical
      journal articles mention it. Outside the medical community, being "scared to
      death" or "worried sick" are expressions that have long been part of the
      popular lexicon, noted epidemiologist Robert Hahn from the Centers for
      Disease Control and Prevention in Atlanta.

      Is such language just hyperbole? Not to those who accept, for example, the
      idea of voodoo death -- a hex so powerful that the victim of the curse dies
      of fright. While many in the scientific community may regard voodoo with
      skepticism, the idea that gut reactions may have biological consequences
      can't be simply dismissed.

      "Surgeons are wary of people who are convinced that they will die," said
      Herbert Benson, a Harvard professor and the president Mind/Body Medical
      Institute in Boston. "There are examples of studies done on people
      undergoing surgery who almost want to die to re-contact a loved one. Close
      to 100 percent of people under those circumstances die."

      But the nocebo effect can lead to more subtle outcomes as well.

      Fifteen years ago, researchers at three medical centers undertook a study of
      aspirin and another blood thinner in heart patients and came up with an
      unexpected result that said little about the heart and much about the brain.
      At two locations, patients were warned of possible gastrointestinal
      problems, one of the most common side effects of repeated use of aspirin. At
      the other location, patients received no such caution.

      When researchers reviewed the data, they found a striking result: Those
      warned about the gastrointestinal problems were almost three times as likely
      to have the side effect. Though the evidence of actual stomach damage such
      as ulcers was the same for all three groups, those with the most information
      about the prospect of minor problems were the most likely to experience the
      pain.

      Despite the smattering of doctors' anecdotal reports and a few modest
      clinical studies, research on the phenomenon has not been robust, mostly for
      ethical reasons: Doctors ought not to induce illness in patients who are not
      sick.

      Changing ethical standards have made it difficult to even repeat some of the
      classic nocebo experiments. In one century-old effort, conducted long before
      anyone thought up the word nocebo, doctors set an allergy sufferer wheezing
      by showing an artificial rose, proving that at least some aspect of the
      allergic response is stimulated by visual cues. In a study from the early
      1980s, 34 college students were told an electric current would be passed
      through their heads, and the researchers warned that the experience could
      cause a headache. Though not a single volt of current was used, more than
      two-thirds of the students reported headaches.

      Medical Distrust

      But resistance to in-depth study of the nocebo effect rests on more than
      ethical reservations, said the CDC's Hahn. Belief, he said, does not have a
      strong place in the anatomy-centered world of modern medicine.

      "The fact is that phenomena that essentially come down to what people
      believe are conceptually difficult in our medical system," Hahn said.
      "Health is thought to be a biological phenomenon. More psychosomatic
      elements are hard to deal with."

      Science is wearing away at the wall between mind and body. With the aid of
      high-tech imaging devices, neurologists are getting better at taking
      pictures of the brain in action. In one blinded study last year, researchers
      found that patients with Parkinson's disease given a placebo released a
      brain chemical called dopamine, just as the brain exposed to an active drug
      would do.

      That flood of brain chemicals, it appears, has everything to do with what
      the mind expects. In most cases, like the Parkinson's study, the outcome is
      positive -- the placebo effect in action. But for some patients --
      depressed, wary of medication or worried about drug side effects -- getting
      a prescription filled is an angst-ridden experience. And such patients
      appear even more likely to exhibit those side effects.

      Barsky has even sketched out a profile of the kind of patient likely to
      experience the nocebo effect -- worse side effects and poorer outcomes -- on
      a given drug. When Barsky sees a patient with a history of vague,
      difficult-to-diagnose complaints who is sure that whatever therapy is
      prescribed will do little to battle the problem, he says, those low
      expectations are inevitably met. The treatments usually fail.

      "Whether you trust your doctor or not probably makes a huge difference in
      whether you report side effects, but there's almost no data on that," Barsky
      said. He hopes to include information about a person's psychology in an
      upcoming placebo-controlled clinical trial to see if patients with a
      particular outlook on life fare better or worse than other subjects.

      Far more esoteric factors may also shape both the placebo and nocebo
      response. A Dutch study, for example, found that most people considered red
      and orange pills to be stimulating, with blue and green-colored pills more
      likely to have a depressant effect.

      "One of the most important things about a pill is [its] color," said Daniel
      Moerman, an anthropologist at the University of Michigan-Dearborn who has
      studied the placebo and nocebo effects across different cultures. "That
      seems to be fairly widespread."

      But the mind is a funny thing, and generic responses to color go just so far
      in explaining the placebo or nocebo response. Consider this: In Italy,
      Moerman says, blue placebos made excellent sleeping pills for women but had
      the opposite effect on men.

      The apparent reason? "The Italian national football team's color is
      azzurri," he said. "Blue."

      ------------

      RELATED NHNE NEWS LIST ARTICLES:

      THE PLACEBO EFFECT: THE POWER OF NOTHING (5/26/2001):
      http://groups.yahoo.com/group/nhnenews/message/1513

      ------------

      NHNE News List:

      To subscribe, send a message to:
      nhnenews-subscribe@yahoogroups.com

      To unsubscribe, send a message to:
      nhnenews-unsubscribe@yahoogroups.com

      To review current posts:
      http://groups.yahoo.com/group/nhnenews/messages

      Published by NewHeavenNewEarth (NHNE)
      eMail: nhne@...
      NHNE Website: http://www.nhne.com/
      Phone: (928) 282-6120
      Fax: (815) 346-1492

      Appreciate what we are doing?
      You can say so with a tax-deductible donation:
      http://www.nhne.com/main/donations.html

      P.O. Box 2242
      Sedona, AZ 86339
    Your message has been successfully submitted and would be delivered to recipients shortly.